Institutional Biosafety Committee (IBC)

All research protocols that propose the use of recombinant DNA must receive prior approval from the Institutional Biosafety Committee (IBC), which meets on the following dates:

Meeting Date Submission Deadline Date
Thursday, January 18, 2018 Wednesday, January 03, 2018
Thursday, February 15, 2018 Wednesday, January 31, 2018
Thursday, March 15, 2018 Wednesday, February 28, 2018
Thursday, April 19, 2018 Wednesday, April 04, 2018
Thursday, May 17 2018 Wednesday, May 02, 2018
Thursday, June 21, 2018 Wednesday, June 06, 2018
Thursday, July 19, 2018 Thursday, July 05, 2018
Thursday, August 16, 2018 Wednesday, August 01, 2018
Thursday, September 20, 2018 Wednesday, September 05, 2018
Thursday, October 18, 2018 Wednesday, October 03, 2018
Thursday, November 15, 2018 Wednesday, October 31, 2018
Thursday, December 20, 2018 Wednesday, December 05, 2018
Thursday, January 17, 2019 Wednesday, January 02, 2019
Guidance Documents
Forms

Each time you fill out a new form, please download it from this website. The forms will be updated periodically.

Human Gene Transfer Research
Educational Materials and Resources
Contact Information

Ellen Kapsalis, Ph.D.
Director of Research Compliance
Compliance Committees (IACUC/IBC/ESCRO)
Office of the Vice Provost for Research
Dominion Tower, Suite 1205G (Locator: R-64)
Phone: (305) 243-2311
Fax: (305) 243-2853
Email: Ekapsali@med.miami.edu